ACES Diagnostics, Inc. files Form D
How this compares
- Among 140 fund launches filed from AZ in the same window it is larger than 34%; the AZ median is $8M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
Sold rose from $1.6M to $3.6M (+$2M, +19 investors) in 630 days since the previous filing.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-10-03 | D | $1.6M | 8 | |
| 2026-06-25 | D | $400K | 2 | −$1.1M |
| 2026-06-25 | D/A | $3.6M | 27 | +$3.2M |
| 2026-10-27 | D | $7.1M | 30 | +$3.5M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Aces Diagnostics on EDGAR
Earlier and related filings by the same issuer and sponsor.
ACES Diagnostics, Inc. raises $400K under Reg D
ACES Diagnostics, Inc. raises $1.6M under Reg D
People on the filing
| Tammy Crawford | Executive Officer, Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Tammy Crawford, CEO.
Why now — by persona
Relevant to: B2B software & services sales, Executive & technical recruiting, Commercial banking / treasury.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.